Literature DB >> 1436456

Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study.

S E Starkstein1, J Brandt, F Bylsma, C Peyser, M Folstein, S E Folstein.   

Abstract

Magnetic resonance imaging and a comprehensive cognitive evaluation were carried out in a series of 29 patients with mild to moderate Huntington's disease (HD). A factor analysis of the neuropsychological test scores provided three factors: a memory/speed-of-processing factor, a "frontal" factor, and a response inhibition factor. The memory/speed factor correlated significantly with measures of caudate atrophy, frontal atrophy, and atrophy of the left (but not the right) sylvian cistern. There were no significant correlations between the "frontal" or response inhibition factors and measures of cortical or subcortical brain atrophy. Our findings confirm that subcortical atrophy is significantly correlated with specific cognitive deficits in HD, and demonstrate that cortical atrophy also has important association with the cognitive deficits of patients with HD.

Entities:  

Mesh:

Year:  1992        PMID: 1436456     DOI: 10.1007/bf00598956

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  Design fluency: the invention of nonsense drawings after focal cortical lesions.

Authors:  M Jones-Gotman; B Milner
Journal:  Neuropsychologia       Date:  1977       Impact factor: 3.139

2.  Magnetic resonance imaging in Huntington disease.

Authors:  J T Simmons; B Pastakia; T N Chase; C W Shults
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

3.  A modified card sorting test sensitive to frontal lobe defects.

Authors:  H E Nelson
Journal:  Cortex       Date:  1976-12       Impact factor: 4.027

4.  Computed tomographic, neurologic, and neuropsychological correlates of Huntington's disease.

Authors:  D S Sax; B O'Donnell; N Butters; L Menzer; K Montgomery; H L Kayne
Journal:  Int J Neurosci       Date:  1983       Impact factor: 2.292

5.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

6.  Brain atrophy in Huntington's disease. A CT-scan study.

Authors:  S E Starkstein; S E Folstein; J Brandt; G D Pearlson; A McDonnell; M Folstein
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

7.  Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study.

Authors:  K A Bamford; E D Caine; D K Kido; W M Plassche; I Shoulson
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

8.  Neuropsychological and neuroradiological correlates in Huntington's disease.

Authors:  S E Starkstein; J Brandt; S Folstein; M Strauss; M L Berthier; G D Pearlson; D Wong; A McDonnell; M Folstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

9.  Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function.

Authors:  S Berent; B Giordani; S Lehtinen; D Markel; J B Penney; H A Buchtel; S Starosta-Rubinstein; R Hichwa; A B Young
Journal:  Ann Neurol       Date:  1988-06       Impact factor: 10.422

10.  The diagnosis of Huntington's disease.

Authors:  S E Folstein; R J Leigh; I M Parhad; M F Folstein
Journal:  Neurology       Date:  1986-10       Impact factor: 9.910

  10 in total
  21 in total

Review 1.  Brain imaging and cognitive dysfunctions in Huntington's disease.

Authors:  Alonso Montoya; Bruce H Price; Matthew Menear; Martin Lepage
Journal:  J Psychiatry Neurosci       Date:  2006-01       Impact factor: 6.186

2.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

3.  Cortical atrophic-hypometabolic dissociation in the transition from premanifest to early-stage Huntington's disease.

Authors:  Frederic Sampedro; Saul Martínez-Horta; Jesús Perez-Perez; Andrea Horta-Barba; Diego Alfonso Lopez-Mora; Valle Camacho; Alejandro Fernández-León; Beatriz Gomez-Anson; Ignasi Carrió; Jaime Kulisevsky
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-09       Impact factor: 9.236

4.  Imaging of Huntington's disease.

Authors:  R S Negi; K L Manchanda; Sunil Sanga
Journal:  Med J Armed Forces India       Date:  2012-10-23

5.  Cognitive and functional decline in Huntington's disease: dementia criteria revisited.

Authors:  Guerry M Peavy; Mark W Jacobson; Jody L Goldstein; Joanne M Hamilton; Amy Kane; Anthony C Gamst; Stephanie L Lessig; J C Lee; Jody Corey-Bloom
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

6.  Neocortical neurotransmitter markers in Huntington's disease.

Authors:  S J Pearson; G P Reynolds
Journal:  J Neural Transm Gen Sect       Date:  1994

7.  EEG low-resolution brain electromagnetic tomography (LORETA) in Huntington's disease.

Authors:  Annamaria Painold; Peter Anderer; Anna K Holl; Martin Letmaier; Gerda M Saletu-Zyhlarz; Bernd Saletu; Raphael M Bonelli
Journal:  J Neurol       Date:  2010-12-12       Impact factor: 4.849

Review 8.  Functional imaging in Huntington's disease.

Authors:  Jane S Paulsen
Journal:  Exp Neurol       Date:  2009-01-03       Impact factor: 5.330

9.  Stable Atlas-based Mapped Prior (STAMP) machine-learning segmentation for multicenter large-scale MRI data.

Authors:  Eun Young Kim; Vincent A Magnotta; Dawei Liu; Hans J Johnson
Journal:  Magn Reson Imaging       Date:  2014-05-09       Impact factor: 2.546

Review 10.  Magnetic resonance imaging of Huntington's disease: preparing for clinical trials.

Authors:  S Klöppel; S M Henley; N Z Hobbs; R C Wolf; J Kassubek; S J Tabrizi; R S J Frackowiak
Journal:  Neuroscience       Date:  2009-01-29       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.